Grant & Eisenhofer’s Beth Graham to Speak on Zofran (ondansetron) Litigation

At the April 2016 Mass Torts Made Perfect conference in Las Vegas later this month, Grant & Eisenhofer Director Elizabeth Graham, co-lead on the Plaintiffs’ Executive Committee of the Zofran (ondansetron) multi-district litigation, will speak to the latest developments in the litigation. Ms. Graham will cover the status of the over 230 cases centralized before Massachusetts District Judge F. Dennis Saylor, all similarly claiming that, among other allegations, GlaxoSmithKline LLC’s “off label marketing” of anti-nausea drug Zofran (ondansetron) to pregnant women led to birth defects.

If you or a loved one took Zofran (ondansetron) for morning sickness during your first trimester and your baby was born with a cleft palate or congenital heart defect, please contact us at 877-978-0169 for a confidential evaluation of your potential claim.

Real Time Analytics